Pharmacologic treatments for covid-19 patients
Clarithromycin vs Standard care
This comparison will not be updated. Last search date 28 Feb, 2022.
To access all information :
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=294
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04622891 Rashad A, Scientific Reports, 2021 Full text Full text Commentary Commentary |
Public/non profit |
Azithromycin Clarithromycin Azithromycin |
Standard care Standard care Clarithromycin |
RCT | Patients with confirmed COVID-19 (mild outpatients) treated at a single center in Egypt | N=305 | N/A | |